Aditum Bio
Oakland, Californiaaditumbio.com
Overview
Aditum Bio is a venture capital firm that focuses on acquiring and developing biotechnology assets. The firm's model involves in-licensing promising drug candidates and creating new companies to advance them through Phase II clinical trials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oblenio Bio | Jun 2026 | Series B | Co-investor |
| Oblenio Bio | Nov 2024 | Series A | Lead |
| Motric Bio | Nov 2021 | Seed | Lead |
| Via Nova Therapeutics | Sep 2021 | Series A | Lead |
| EmbarkNeuro | Jun 2021 | Seed | Lead |
Key People
Josh Gertsman
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
